Over 80% of people with AFib on blood thinners are open to trying a new treatment to lower their stroke risk.2
The WATCHMAN™ device effectively reduces the risk of stroke—without the risk of bleeding that can come with the long-term use of blood thinners.3,4 This makes left atrial appendage closure (LAAC) therapy an important option for patients with a history or risk of serious bleeding on blood thinners.